Publications:

Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy.

Journal Of Virology

Shiu, Carlum C; Cunningham, Coleen K CK; Greenough, Thomas T; Muresan, Petronella P; Sanchez-Merino, Victor V; Carey, Vincent V; Jackson, J Brooks JB; Ziemniak, Carrie C; Fox, Lawrence L; Belzer, Marvin M; Ray, Stuart C SC; Luzuriaga, Katherine K; Persaud, Deborah D; ,

Publication Date: 2009-10

Variant appearance in text: CD4: E194G

PubMed Link: 19605490

Variant Present in the following documents:

• Main text

View BVdb publication page

Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutations.

Antimicrobial Agents And Chemotherapy

Oliveira, Maureen M; Moisi, Daniela D; Spira, Bonnie B; Cox, Susan S; Brenner, Bluma G BG; Wainberg, Mark A MA

Publication Date: 2009-04

Variant appearance in text: CD4: E194G

PubMed Link: 19223637

Variant Present in the following documents:

• Main text

View BVdb publication page